Rontalizumab is a humanized monoclonal antibody [1] being developed by Genentech .[2] As of November 2009[update] , it is being investigated in a clinical trial for the treatment of systemic lupus erythematosus .[3]
References [ edit ]
Immune system ("-l(i[m])-")
Human ("-limu-") Mouse ("-limo-") Chimeric ("-lixi-")Humanized ("-lizu-")Chimeric + humanized ("-lixizu-")
Interleukin ("-k(i[n])-")
Human ("-kinu-") Humanized ("-kizu-", "-kinzu-") Veterinary ("-kivet-")
Inflammatory lesions ("-les-")
Chemokine CSF
Interferon
IFNAR (α/β, I)
Agonists: Albinterferon
Interferon alpha (interferon alfa, IFN-α)
Interferon alfa (IFNA1 , IFNA2 , IFNA4 , IFNA5 , IFNA6 , IFNA7 , IFNA8 , IFNA10 , IFNA13 , IFNA14 , IFNA16 , IFNA17 , IFNA21 )
Interferon alfa 2a
Interferon alfa 2b
Interferon alfa n1
Interferon alfacon-1
Interferon alpha-n3
Interferon beta (IFN-β) (IFNB1 , IFNB3 )
Interferon beta 1a
Interferon beta 1b
Interferon kappa (IFN-ε/κ/τ/ζ, IFNK)
Interferon omega (IFN-ω, IFNW1)
Peginterferon alfa-2a
Peginterferon alfa-2b
IFNGR (γ, II) IFNLR (λ, III)
See IL-28R (IFNLR) here instead.
Interleukin TGFβ TNF Others